General Information of the Compound
| Compound ID |
CP0505708
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(1-(3,5-bis(4-(trifluoromethoxy)phenyl)-1H-pyrazol-1-yl)ethyl)-N-(2H-tetrazol-5-yl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C27H19F6N7O3
|
||||||||||||||||||
| Molecular Weight |
603.483
|
||||||||||||||||||
| Canonical SMILES |
CC(c1ccc(cc1)C(=O)Nc1nnn[nH]1)n1nc(cc1-c1ccc(OC(F)(F)F)cc1)-c1ccc(OC(F)(F)F)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H19F6N7O3/c1-15(16-2-4-19(5-3-16)24(41)34-25-35-38-39-36-25)40-23(18-8-12-21(13-9-18)43-27(31,32)33)14-22(37-40)17-6-10-20(11-7-17)42-26(28,29)30/h2-15H,1H3,(H2,34,35,36,38,39,41)
Show/Hide
|
||||||||||||||||||
| InChIKey |
UCXDATDHRBYGIQ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02242, Gastric inhibitory polypeptide receptor
Protein ID: PT01473, Glucagon receptor